Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 401 entries
View as:

Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial

Phase: N/A Priority: Normal
NCT ID: NCT06310473 Org: User:
Start: 03/31/24 End: 03/31/28 Due: 03/31/29

Mother-to-child Transmission of HBV in China

Phase: N/A Priority: Normal
NCT ID: NCT05172453 Org: User:
Start: 07/01/15 End: 12/31/25 Due: 12/31/26

Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AML

Phase: N/A Priority: Normal
NCT ID: NCT03642236 Org: User:
Start: 08/31/18 End: 09/30/23 Due: 09/30/24

Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01457040 Org: User:
Start: 10/31/11 End: 12/31/16 Due: 12/31/17

Small Intestinal Submucosa Scaffold Combined With Adipose-derived Stem Cells to Form an Adipocyte-containing Hypodermis

Phase: N/A Priority: Normal
NCT ID: NCT02560350 Org: User:
Start: 08/31/15 End: 08/31/16 Due: 08/31/17

Association of Hb F Level With Clinical Severity of Beta Thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT04917978 Org: User:
Start: 12/01/19 End: 12/30/25 Due: 12/30/26

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06155188 Org: User:
Start: 09/29/19 End: 12/31/26 Due: 12/31/27

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Phase: N/A Priority: Normal
NCT ID: NCT05644314 Org: User:
Start: 05/01/22 End: 05/31/29 Due: 05/31/30

Diaphragm Dysfunction After COVID-19 as Determined by Dynamic Chest Radiography

Phase: N/A Priority: Normal
NCT ID: NCT06175455 Org: User:
Start: 11/10/23 End: 03/10/25 Due: 03/10/26

MRD-directed Therapy for Low-risk and Intermediate-risk AML.

Phase: N/A Priority: Normal
NCT ID: NCT02870777 Org: User:
Start: 08/31/16 End: 12/31/19 Due: 12/31/20

Withdrawal or Reduction TKIs in CML-CP

Phase: N/A Priority: Normal
NCT ID: NCT04143087 Org: User:
Start: 10/23/19 End: 12/31/21 Due: 12/31/22

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT03530085 Org: User:
Start: 06/15/18 End: 04/01/22 Due: 04/01/23

An Open-label, Multicenter, Single-arm Clinical Study on the Use of Doxorubicin Liposome in Combination With CapOX and Bevacizumab Regimen for First-line Treatment of Advanced Colorectal Adenocarcinoma With SMAD4R361H/C Mutation.

Phase: N/A Priority: Normal
NCT ID: NCT06753721 Org: User:
Start: 12/31/24 End: 06/01/27 Due: 06/01/28

BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT03733327 Org: User:
Start: 11/30/18 End: 10/31/21 Due: 10/31/22

The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism

Phase: N/A Priority: Normal
NCT ID: NCT06192199 Org: User:
Start: 01/01/18 End: 12/01/26 Due: 12/01/27

Shugan Jieyu Capsule for Insomnia Patients With Depressive Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT05764798 Org: User:
Start: 11/30/22 End: 12/30/24 Due: 12/30/25

The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM

Phase: N/A Priority: Normal
NCT ID: NCT03686254 Org: User:
Start: 07/16/18 End: 10/01/23 Due: 10/01/24

A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06843889 Org: User:
Start: 04/03/25 End: 08/01/28 Due: 08/01/29

MSC for Treatment of CMV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02083731 Org: User:
Start: 01/31/14 End: 01/31/17 Due: 01/31/18

Effects of Ulinastatin on Inflammatory Response During ECMO Support

Phase: N/A Priority: Normal
NCT ID: NCT04990752 Org: User:
Start: 07/26/21 End: 06/01/23 Due: 06/01/24

Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants

Phase: N/A Priority: Normal
NCT ID: NCT03624530 Org: User:
Start: 08/31/18 End: 07/31/22 Due: 07/31/23

Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06017895 Org: User:
Start: 10/31/23 End: 02/28/26 Due: 02/28/27

Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801)

Phase: N/A Priority: Normal
NCT ID: NCT03778775 Org: User:
Start: 12/14/18 End: 03/13/22 Due: 03/13/23

Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT04688138 Org: User:
Start: 06/01/20 End: 06/30/23 Due: 06/30/24

Optical Biopsy for Peritoneal Nodules in Colorectal Patients

Phase: N/A Priority: Normal
NCT ID: NCT05879783 Org: User:
Start: 09/15/22 End: 12/15/27 Due: 12/15/28